CRISPR and CAS Gene Technology Market Trends

Growth Drivers

Rising Applications of CRISPR and CAS Gene Technology in Various Fields -

The increasing number of diseases such as HIV, sickle cell disease, transthyretin amyloidosis, and other disorders that affect the immune system and genes of the body is estimated to drive market growth. The increasing use of genetic engineering techniques to modify defective genes is propelling market growth during the forecast period.

As per the Centers for Disease Control and Prevention, in 2020 about 30,635 people in the U.S. were diagnosed with HIV.

Increasing Government and Private Funding for Medical Research – The National Institutes of Health (NIH) invested most of its budget which is USD 45 billion in medical research activities for Americans in 2021 and it was reported that 2 billion is spent on medical research by NIH every year.
Rising Incidence of Genetic Abnormalities in Humans for Various Reasons – The total number of cases of dengue in America between 1^st and 2^nd epidemiological week in 2022 was estimated to be over 3,120,350 cases.
Growing Food Crisis across the World with Rising Urbanization – The Department of Biotechnology in India funded 51 Biotech-Kisan hubs for the farmers to connect them with well-experienced scientists and institutions according to Invest India. As of 2022 data, 44 of 51 operational hubs are situated in 15 Agro-climatic zones of the nation and conduct operations in an overall 169 districts in India.
Increasing Cancer Cases with Gene Mutations Caused by UV radiation and Hydrofluorocarbons in Air – More than 300, 580 new breast cancer cases are projected to rise in the United States by the end of 2023.

Challenges

Pending Patent Concerns & Outcomes of Clinical Trials Associated with the Technology
Ethical Concern on Genetically Modified Foods and Organisms by CRISPR and CAS gene technology – The generation of these genetically modified foods and changes in the organisms is ethically not safe as it alters the germline of humans which is estimated to hamper the market growth. The CRISPR gene technology is to treat the mutated genes in patients to treat diseases that alter the natural DNA sequence of humans which is considered immoral is hampering the market growth.
Requirement for Professionals, High Cost of Investment, and Time Consumption

CRISPR and CAS Gene Technology Market: Key Insights

Base Year	2024
Forecast Year	2025-2037
CAGR	20.4%
Base Year Market Size (2024)	USD 4.85 billion
Forecast Year Market Size (2037)	USD 33.05 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of CRISPR and CAS gene technology is estimated at USD 5.65 billion.

The CRISPR and CAS gene technology market size was over USD 4.85 billion in 2024 and is likely to cross USD 33.05 billion by the end of 2037, witnessing more than 20.4% CAGR during the forecast period i.e., between 2025-2037. The rising applications of CRISPR and CAS gene technology and the increasing government and private funding for medical research will impel the market growth.

North American industry is projected to have the highest growth through 2037, led by increasing investment of governmental and non-governmental agencies in R&D activities.

The major players in the market include Thermo Fisher Scientific Holdings, Inc., Origene Technologies, Addgene, Inc., Merck KGaA, GenScript Biotech, Cellecta, Inc., Caribou Bioscience, Inc., Horizon Discovery Group, Mammoth Biosciences, Inc., Inscripta, Inc.

CRISPR and CAS Gene Technology Market Trends